GOLD STANDARD DIAGNOSTICS
LIVE

Serial Number

79975865

Owner

EUROFINS SCIENTIFIC (IRELAND) LIMITED

Attorney

Joseph Sofer

Filing Date

Nov 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GOLD STANDARD DIAGNOSTICS Trademark

Serial Number: 79975865 • Registration: 7998685

GOLD STANDARD DIAGNOSTICS is a trademark filed by EUROFINS SCIENTIFIC (IRELAND) LIMITED on November 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EUROFINS SCIENTIFIC (IRELAND) LIMITED (44 trademarks)

Entity Type: 99

Trademark Details

Filing Date

November 13, 2023

Registration Date

October 28, 2025

Published for Opposition

September 9, 2025

Goods & Services

Scientific research and industrial research in the fields of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry, pharmacology, cosmetic, biopharmaceutical, biotechnology, nutraceutical, food and feed industries; Scientific research and development in the fields of animal and plant biology, physical chemistry, food chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; Scientific research in the nature of carrying out physical, chemical, physico-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, or immunological analyses in the fields of plant and animal products; Scientific research in the nature of performance of physical analyses, chemical, physico-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, or immunological, and clinical and in vitro studies, in the food, animal food, agri-food, chemical, pharmaceutical, cosmetic, health, environmental, agrochemical, biotechnology and any other science related industry; Scientific research in the nature of carrying out genetic analyses in the fields of plant and animal products; Scientific research in the nature of carrying out genetic analyses in the field of the food, feed, agri-food, chemical, pharmaceutical, cosmetic, health, biotechnology and consumer product, and environmental testing industries; Scientific research and development of methods, namely, establishing and conducting physical, chemical, physical-chemical, biochemical, organic, epidemiological, microbiological, molecular biological, immunological and biomolecular testing methods; preparing scientific research reports, industrial research expert reports for scientists and engineers in the field of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry, pharmacology, cosmetic, biopharmaceutical, biotechnology, nutraceutical, food and feed industries; DNA, RNA and virus testing for scientific research purposes; consultation and advisory services relating to product development in the field of goods manufactured by the pharmaceutical, chemical, biotechnology, and any other science-related industry; product development consultation and advisory services for developing product manufacturing; research and development of new products in the pharmaceutical, biotechnological, chemical and agro-chemical fields; Scientific research services in the areas of genomics, proteomics, chemistry, pharmacology, biology, epidemiology, medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry and computational chemistry; Providing scientific research information in the fields of epidemiology, genomics and proteomics of living organisms including human beings based on existing biological data and using computer tools and techniques; scientific and technological services, namely, scientific and medical research laboratory services, medical laboratory research and product research and development in the fields of epidemiology, biomedicine and biobanks; Design and testing for new product development for veterinary products and their applications.

Computerized medical and veterinary recording and analysis apparatus for the diagnosis and treatment of infectious disease, auto-immune diseases, oncology, hormone disorders; Diagnostic medical laboratory equipment, namely test sample containers and tubes for samples for medical and veterinary use; Test sample containers and sample preparation devices for diagnostic medical and veterinary use; test kits for medical analysis and diagnosis for medical and veterinary use, namely, test sample collection tubes; Test sample collection kits for medical analysis and diagnostics for medical and veterinary use, namely tubes, stoppers ; test strips, lancets; Test box comprising test sample collection tubes; medical diagnostic apparatus in the nature of blotters for Guthrie testing; medical diagnostic apparatus and instruments, namely, test strip readers, magnetic separators, automated analysis apparatus comprising an optical reader for microplates for medical and veterinary diagnostic use; medical diagnostic apparatus and instruments, namely, non-automated analysis apparatus comprising an optical microplate reader, a strip microplate reader, a test strip reader, a tube reader, a photometer, a microplate reader for medical and veterinary diagnostic use; medical diagnostic apparatus and instruments for measuring the concentration of analytes from aqueous samples for medical and veterinary diagnostic use; Medical diagnostic Enzyme-Linked Immunoabsorbant Assay (ELISA) and other antibody-based kits, namely, test bands and strips, microtiter plates, coated test tubes and magnetic particles for the detection of chemical and biochemical and biological molecules or parts thereof for medical and veterinary diagnostic use.

Medical laboratory measuring apparatus, diagnostic apparatus, and analysis apparatus, namely, Enzyme-Linked Immunosorbent Assay (ELISA) test readers, Enzyme-Linked Immunosorbent Assay (ELISA) analyzers, lateral flow test strip readers, photometers, liquid analyzers, nanoparticle size analyzers, infrared spectrometers, and nuclear magnetic resonance (NMR) spectroscopy apparatus, not for medical use; Diagnostic medical laboratory equipment, namely sample containers and tubes for samples for medical and veterinary use; sample containers and sample devices for scientific and laboratory use; Downloadable software for establishment, systematization, evaluation and/or collection of analytical or diagnostic data; DNA microchips; peptide microchips in the nature of DNA microchips; DNA microarrays; peptide microarrays; Biochips for research or scientific purposes; laboratory instruments for analysis and diagnosis not for medical use, namely, test tubes; scientific laboratory apparatuses and instruments, namely, test strip readers, magnetic separators, and automated analysis apparatuses comprising an optical reader for microplates; scientific apparatus and instruments, namely, non-automated analysis apparatus comprising an optical and microplate reader, a tape microplate reader, a test strip reader, a tube reader, a photometer, a microplate reader for scientific, laboratory, or industrial use and not for medical diagnostic use; scientific laboratory apparatuses and instruments for measuring the concentration of analytes from aqueous samples for scientific, laboratory, or industrial use not for medical diagnostic use.

Diagnostic preparations for medical and veterinary use; diagnostic reagents for medical and veterinary use; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely infectious disease, auto-immune diseases, oncology, hormone disorders for medical and veterinary use ; chemical reagents for carrying out analytical tests for medical and veterinary purposes; chemical reagents for medical and veterinary use; chemical preparations for medical and veterinary use, namely for microbiology, for detecting epidemiological risks, infectious diseases or auto-immune diseases, for supporting vaccines ; organic chemical reagents for medical or veterinary use; analytical and diagnostic testing kits for medical and veterinary use comprising diagnostic reagents and assays; PCR kits, namely analytical and diagnostic test kits for medical use consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; PCR kits, namely, reagents and control samples for medical or veterinary diagnostic purposes; analytical standard solutions for detection of chemical and biochemical molecules for medical diagnostic and veterinary diagnostic use; chemically-modified magnetic beads for binding chemical or biochemical compounds for detection of chemical and biochemical compounds for medical diagnostic and veterinary diagnostic use; diagnostic test kits comprising proteins, polypeptides and chemical reagents for medical and veterinary purposes.

Medical services for diagnostic or treatment purposes, namely blood analysis, saliva, urine, tissue, hair and body fluid analysis services; Medical testing for diagnostic or treatment purposes, namely serology and urinary testing for medical, epidemiological and veterinary purpose; medical testing services in the fields of epidemiology and genetics for diagnostic or treatment purposes; medical and health care services related to DNA and RNA; genetic analysis for medical diagnostic or treatment use; medical assistance and medical services in the fields of epidemiology and genetics; medical clinic services; collection, sampling and preservation of human blood, saliva, urine, tissues, hair and body fluids for medical diagnostic or treatment purposes; medical testing services for diagnostic and epidemiological purposes; medical diagnostic testing, monitoring and reporting in the field of cardiovascular disease; medical testing for diagnostic and treatment purposes, namely, for the genetic causes of lipid abnormalities; medical diagnostic testing in the field of diabetes; medical testing for diagnostic purposes in the fields of preventive medicine; medical services, namely, preventive medicine and testing in the field of micro-nutrition; medical diagnostic testing in the field of anti-aging medicine; medical assistance services in the field of preventive medicine; Providing medical information in the nature of bio-pathological information and advice relating to medical biology testing; conducting tests to determine immunogenicity, hypersensitivity and adverse immune stimulation for medical diagnostic or treatment purposes; conducting allergy and immunology tests for medical diagnostic or treatment purposes; infectious disease testing for medical diagnostic or treatment purposes; conducting prenatal diagnostic tests for medical diagnostic purposes; conducting prenatal diagnostic tests for treatment purposes.

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
May 29, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
May 29, 2026 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 28, 2026 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 26, 2025 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2025 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 6, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 20, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 20, 2025 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 13, 2025 CNRT
DIVISIONAL PROCESSING COMPLETE
Jan 28, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 14, 2025 AITU
DIVISIONAL REQUEST RECEIVED
Jan 8, 2025 DRRR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2025 TROA
TEAS REQUEST TO DIVIDE RECEIVED
Jan 8, 2025 ERTD
REFUSAL PROCESSED BY IB
Jul 28, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 10, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 10, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 21, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 20, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 19, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 23, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 2, 2024 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 21, 2023 SDRC